282 related articles for article (PubMed ID: 23273969)
1. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
3. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
4. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
6. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
[TBL] [Abstract][Full Text] [Related]
7. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
9. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
10. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
[TBL] [Abstract][Full Text] [Related]
11. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
12. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
13. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
[TBL] [Abstract][Full Text] [Related]
14. [Are teenagers immunized in infancy still protected against hepatitis B?].
Pokorska-Lis M; Marczyńska M
Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
[TBL] [Abstract][Full Text] [Related]
15. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
[TBL] [Abstract][Full Text] [Related]
16. [Effect of plasma-derived hepatitis B vaccine 23(rd) year after a full course of vaccination in healthy young children].
Wu Q; Wang XL; Deng YL; Wang LR; Gao HY; Zhuang GH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Oct; 45(10):920-3. PubMed ID: 22321594
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
18. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
20. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
